Durable Responses With Front‐Line Rituximab in Autoimmune Cytopenias Associated With Indolent B‐Cell Clones
American Journal of Hematology · 2025
DOI: 10.1002/ajh.27754 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Hematology, 2025. Verfasst von Yoann Zadro und 49 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, IUCT-Oncopole-Toulouse University Hospital, Toulouse University, Toulouse, France. Hauptthemen laut MEDLINE: Autoimmune Diseases, B-Lymphocytes, Rituximab. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, IUCT-Oncopole-Toulouse University Hospital, Toulouse University, Toulouse, France.
- Department of Biostatistics, IUCT-Oncopole, Oncopole Claudius Regaud, Toulouse, France.
- Department of Clinical Research, IUCT-Oncopole-Toulouse University Hospital, Toulouse University, Toulouse, France.
- Department of Internal Medicine, Nantes University Hospital, Nantes University, Nantes, France.
- Department of Internal Medicine, Infectious and Blood Diseases, Cornouaille Quimper-Concarneau Hospital, Quimper, France.
- Maladies du Sang, Angers University Hospital, Angers University, Angers, France.
ORCID-Profile: Yoann Zadro, Corentin Orvain, Étienne Crickx, Sébastien Humbert, Jean-Baptiste Rieu, Guillaume Denis, Christian Lavigne, Arsène Mekinian, Marc Michel, Loïc Ysebaert, Thibault Comont
Zitieren
APA
Zadro, Y., Lusque, A., Rey, H., Cougoul, P., Dion, J., Graveleau, J., Lemarié, F., Le Clech, L., Orvain, C., Domnariu, P. A., Gourguechon, C., Crickx, É., Laribi, K., Gobert, D., Adjoumani, L., Berthoux, É., Deroux, A., Durel, M., Ebbo, M., …, & Comont, T. (2025). Durable Responses With Front‐Line Rituximab in Autoimmune Cytopenias Associated With Indolent B‐Cell Clones. American Journal of Hematology. https://doi.org/10.1002/ajh.27754
Vancouver
Zadro Y, Lusque A, Rey H, Cougoul P, Dion J, Graveleau J, et al. Durable Responses With Front‐Line Rituximab in Autoimmune Cytopenias Associated With Indolent B‐Cell Clones. American Journal of Hematology. 2025. doi:10.1002/ajh.27754
BibTeX
@article{Zadro2025,
author = {Zadro, Yoann and Lusque, Amélie and Rey, Héloïse and Cougoul, Pierre and Dion, Jérémie and Graveleau, Julie and Lemarié, Fanny and Le Clech, Lenaïg and Orvain, Corentin and Domnariu, Paul Albert and Gourguechon, Clément and Crickx, Étienne and Laribi, Kamel and Gobert, Delphine and Adjoumani, Léonce and Berthoux, Émilie and Deroux, Alban and Durel, Marie and Ebbo, Mikael and Farhi, Jonathan and Humbert, Sébastien and Jachiet, Vincent and Thomazeau, Joséphine and Castel, Brice and Begey, Clément and Rieu, Jean-Baptiste and Deshayes, Samuel and Devaux, Mathilde and Durieu, Isabelle and Gauthier, Martin and Loirat, Marion and Rivière, Étienne and Viallard, Jean-Francois and Martis, Nihal and Jeandel, Pierre-Yves and Paillassa, Jérôme and Denis, Guillaume and Hadj-Khelifa, Sondess and Lavigne, Christian and Lifermann, François and Andrès, Emmanuel and Dumontet, Charles and Grobost, Vincent and Sauvetre, Gaétan and Mekinian, Arsène and Michel, Marc and Godeau, Bertrand and Ysebaert, Loïc and Moulis, Guillaume and Comont, Thibault},
title = {Durable Responses With Front‐Line Rituximab in Autoimmune Cytopenias Associated With Indolent B‐Cell Clones},
journal = {American Journal of Hematology},
year = {2025},
doi = {10.1002/ajh.27754}
}
EUVIMED